David A. Socks, SVP at CADENCE PHARMACEUTICALS INC (CADX), sold 12,500 shares at $11.60 ($145K) on 2009-10-12, disclosed to the SEC on 2009-10-13.
Scheduled sale ($145k) by SVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PHAT | SELL | 2021-08-18 | $1.1M | — | Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |